CytoCore Inc Sample Contracts

AutoNDA by SimpleDocs
RECITALS
Lease • March 29th, 2001 • Ampersand Medical Corp • Textile mill products • Illinois
ISSUE DATE: VOID AFTER 3:00 P.M., CENTRAL TIME, ON THE FIFTH ANNIVERSARY OF THE ISSUE DATE
Molecular Diagnostics Inc • July 21st, 2003 • Surgical & medical instruments & apparatus • Illinois
1 EXHIBIT 10.32 414 N. ORLEANS, CHICAGO, ILLINOIS OFFICE BUILDING LEASE
Ampersand Medical Corp • March 29th, 2001 • Textile mill products
WARRANT TO PURCHASE COMMON STOCK OF AMPERSAND MEDICAL CORPORATION
Ampersand Medical Corp • August 24th, 2001 • Surgical & medical instruments & apparatus • Illinois
INDENTURE
Indenture • July 21st, 2003 • Molecular Diagnostics Inc • Surgical & medical instruments & apparatus • Illinois
RECITALS
Consulting Agreement • April 14th, 2004 • Molecular Diagnostics Inc • Surgical & medical instruments & apparatus • California
EXHIBIT # 10.49
Consulting Agreement • November 19th, 2003 • Molecular Diagnostics Inc • Surgical & medical instruments & apparatus • Illinois
1 RESTRICTED STOCK AWARD AGREEMENT
Restricted Stock Award Agreement • March 29th, 2001 • Ampersand Medical Corp • Textile mill products
1 EXHIBIT 10.37 AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • March 29th, 2001 • Ampersand Medical Corp • Textile mill products • Illinois
BETWEEN MOLECULAR DIAGNOSTICS, INC. AND
Escrow Agreement • November 17th, 2004 • Molecular Diagnostics Inc • Surgical & medical instruments & apparatus • New York
RECITALS --------
Employment Agreement • March 31st, 1999 • Bell National Corp • Textile mill products • Illinois
AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT MEDITE CANCER DIAGNOSTICS, INC.
Medite Cancer Diagnostics, Inc. • October 2nd, 2017 • Surgical & medical instruments & apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, GPB DEBT HOLDINGS II, LLC, or its successors and assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time six (6) months after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”), up to Four Million One Hundred Twenty Thousand Three Hundred and Eighty (4,120,308) shares of Common Stock (subject to adjustment hereunder, the “Warrant Shares”). The initial exercise price per share of the Common Stock under this Warrant (the “Exercise Price”) shall be equal to $0.60, subject to adjustment as provided below. The purchase price of one Warrant Share under this Warrant shall be equal t

JANUARY 2000
Ampersand Medical Corp • March 29th, 2001 • Textile mill products
RECITALS
Settlement Agreement and Mutual Release • November 21st, 2005 • Molecular Diagnostics Inc • Surgical & medical instruments & apparatus • North Carolina
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • August 14th, 1997 • Bell National Corp • Textile mill products
BETWEEN MOLECULAR DIAGNOSTICS, INC. AND
Stock Purchase Agreement • November 15th, 2004 • Molecular Diagnostics Inc • Surgical & medical instruments & apparatus • New York
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • October 2nd, 2017 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York

This Registration Rights Agreement (as it may be amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of September 26, 2017, by and among Medite Cancer Diagnostics, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and permitted assigns, the “Purchaser”).

PURCHASE AGREEMENT
Purchase Agreement • April 3rd, 2008 • CytoCore Inc • Surgical & medical instruments & apparatus • Illinois

THIS PURCHASE AGREEMENT (“Agreement”) is made as of the day of , 2008, by and between Cytocore, Inc., a Delaware corporation (the “Company”), and the Investor set forth on the signature page affixed hereto (an “Investor”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!